Q3 2018 Holdings
Filed 2018-11-13 | 212 holdings | $297.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $138.3M | 391,402 | 46.5% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $46.5M | 492,078 | 15.7% |
| Boston Scientific Corporation(BSX) | Common | 101137107 | $17.1M | 444,991 | 5.8% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $14.8M | 85,755 | 5.0% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $13.6M | 140,538 | 4.6% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $11.0M | 126,176 | 3.7% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $9.6M | 272,400 | 3.2% |
| Cellectis SA(CLLS) | Sponsored ADR | 15117K103 | $7.9M | 278,988 | 2.6% |
| Bausch Health Companies Inc.(BHC) | Common | 071734107 | $4.9M | 192,000 | 1.7% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $4.8M | 351,618 | 1.6% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $4.7M | 65,714 | 1.6% |
| Align Technology, Inc.(ALGN) | Common | 016255101 | $4.4M | 11,244 | 1.5% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $3.1M | 22,670 | 1.0% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $2.8M | 639,370 | 0.9% |
| Agios Pharmaceuticals, Inc.(AGIO) | Common | 00847X104 | $2.6M | 33,870 | 0.9% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $2.5M | 149,820 | 0.8% |
| Akebia Therapeutics, Inc.(AKBA) | Common | 00972D105 | $2.4M | 266,612 | 0.8% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $1.9M | 93,689 | 0.7% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $1.2M | 15,188 | 0.4% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $706.0K | 203,935 | 0.2% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $150.0K | 1,942,317 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $140.5K | 677,855 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $137.8K | 996,968 | 0.0% |
| Celgene Corporation(CELG) | Common | 151020104 | $117.4K | 1,312,350 | 0.0% |
| Unitedhealth Group Incorporated(UNH) | Common | 91324P102 | $91.6K | 344,486 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $89.1K | 242,717 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $78.7K | 408,235 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $60.9K | 438,416 | 0.0% |
| Mylan N.V. | Shares | N59465109 | $60.6K | 1,657,017 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $59.7K | 1,354,093 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $59.1K | 146,237 | 0.0% |
| Allergan plc | Shares | G0177J108 | $47.4K | 248,836 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $45.8K | 645,208 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $44.6K | 645,442 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $44.0K | 180,395 | 0.0% |
| Anthem, Inc.(ELV) | Common | 036752103 | $38.7K | 141,147 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $36.0K | 223,182 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $33.4K | 339,439 | 0.0% |
| CVS Health Corporation(CVS) | Common | 126650100 | $31.6K | 401,101 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $28.7K | 391,719 | 0.0% |
| Stryker Corporation(SYK) | Common | 863667101 | $28.5K | 160,432 | 0.0% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $28.4K | 718,624 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $27.8K | 322,690 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $26.1K | 212,630 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $25.6K | 102,403 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $24.2K | 166,869 | 0.0% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $23.2K | 216,442 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $23.2K | 68,487 | 0.0% |
| Danaher Corporation(DHR) | Common | 235851102 | $22.8K | 209,371 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $22.7K | 366,064 | 0.0% |